Résultats de la recherche
10
Tout
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
03 févr. 2025 06h22 HE
|
Annovis Bio, Inc.
MALVERN, Pa., Feb. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...